Voyager has also raised the size of its stock sale from 11 million shares to 12.35 million. At $57 a share, Voyager is worth about $3.5 billion on a fully diluted basis.

Dylan Taylor, Voyager Technologies chairman & CEO, joins 'Fast Money' to react to the company's first earnings report since ...

Firefly Aerospace increased the expected price range for its upcoming initial public offering (IPO), now targeting $41 to $43 ...

Key Points Voyager Technologies was supposed to IPO for a price as low as $26 a share -- but didn't. IPO shares began trading on their first day near $70 a share. They've gone nowhere but down since.

NYSE: VOYG] ("Voyager" or the "Company"), today announced financial results for the second quarter 2025. Completed IPO, ...

Voyager set the stage for this IPO with a $60 million crossover round unveiled last April. Over the past few weeks, though, the sudden notoriety that Turing CEO Martin Shkreli gained by jacking up ...

And here's the best part: Whereas ISS cost $100 billion to build, Voyager said it expects to build and launch its Starlab for "approximately $2.8 billion to $3.3 billion." How to value the Voyager IPO ...

Investing.com -- Today’s IPO for space exploration company Voyager Technologies (NYSE:VOYG) opened for trading at $69.75 after pricing its IPO at $31 per share. The company sold 12,348,387 shares in ...

Voyager shares opened at 1:10 p.m. Eastern time on the New York Stock Exchange at $67, or 116.1% above the $31 IPO price. They then pared some gains, and closed the day at $56.48, up 82.2%.

As Wall Street vacillates on the whole biotech sector, each week becomes an unwitting referendum on just how long the IPO window for drug developers might stay open. Voyager Therapeutics and Wave ...

Voyager’s proposed $86 million offering shows the effects of the recent biotech downturn, coming in significantly less than fellow gene therapy firms bluebird bio and Spark Therapeutics.